Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Autor: Takhar, Pam¹ (AUTHOR) pam.takhar@ontariohealth.ca, Geirnaert, Marc² (AUTHOR) mgeirnaert@cancercare.mb.ca, Gavura, Scott¹ (AUTHOR) scott.gavura@ontariohealth.ca, Beca, Jaclyn^1,3 (AUTHOR) jaclyn.beca@mail.utoronto.ca, Mercer, Rebecca E.^1,3,4 (AUTHOR) matthew.cheung@sunnybrook.ca, Denburg, Avram⁵ (AUTHOR), Muñoz, Caroline^1,3 (AUTHOR) caroline.munoz@ontariohealth.ca, Tadrous, Mina^6,7 (AUTHOR) mina.tadrous@utoronto.ca, Parmar, Ambica^8,9 (AUTHOR) ambika.parmar@sunnybrook.ca, Dionne, Francois¹⁰ (AUTHOR) fdionne@telus.net, Boehm, Darryl¹¹ (AUTHOR) darryl.boehm@saskcancer.ca, Chambers, Carole¹² (AUTHOR) carole.chambers@albertahealthservices.ca, Craig, Erica¹³ (AUTHOR) erica.craig@gnb.ca, Trudeau, Maureen⁸ (AUTHOR) maureen.trudeau@sunnybrook.ca, Cheung, Matthew C.^4,8,9 (AUTHOR), Houlihan, Joanne¹⁴ (AUTHOR) joanne.houlihan@nshealth.ca, McDonald, Valerie¹⁵ (AUTHOR) vmcdonald356@gmail.com, Pechlivanoglou, Petros¹⁶ (AUTHOR) petros.pechlivanoglou@sickkids.ca, Taylor, Marianne¹⁷ (AUTHOR) mtaylor@bccancer.bc.ca, Wasylenko, Eric^18,19 (AUTHOR) ericwasylenko@platinum.ca

Publikováno v: Current Oncology. Apr2024, Vol. 31 Issue 4, p1876-1898. 23p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD)

Autor: Xavier Badia, Miguel Ángel Calleja, Vicente Escudero-Vilaplana, Antonio Pérez-Martínez, José Luis Piñana, José Luis Poveda, Joan-Antoni Vallès

Publikováno v: Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-13 (2024)

Abstract Background The aim of this study was to assess the contribution of the reflective multidisciplinary discussion in determining the value contribution of innovative drugs through the multi-criteria decision analysis (MCDA). This methodology co

Externí odkaz: https://doaj.org/article/4d63a80e3d964c45aa87a2e03bd1deca